nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0914	0.17	CbGbCtD
Oxycodone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0914	0.17	CbGbCtD
Oxycodone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0814	0.152	CbGbCtD
Oxycodone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0767	0.143	CbGbCtD
Oxycodone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0518	0.0965	CbGbCtD
Oxycodone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0494	0.0921	CbGbCtD
Oxycodone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.044	0.0821	CbGbCtD
Oxycodone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0258	0.0482	CbGbCtD
Oxycodone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0244	0.0455	CbGbCtD
Oxycodone—Galantamine—CHRNA5—chronic obstructive pulmonary disease	0.00547	0.454	CrCbGaD
Oxycodone—Naloxone—TLR4—chronic obstructive pulmonary disease	0.00356	0.296	CrCbGaD
Oxycodone—Galantamine—CHRNA3—chronic obstructive pulmonary disease	0.00256	0.213	CrCbGaD
Oxycodone—Naloxone—ALB—chronic obstructive pulmonary disease	0.000445	0.037	CrCbGaD
Oxycodone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000401	0.000998	CcSEcCtD
Oxycodone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.000992	CcSEcCtD
Oxycodone—Infection—Formoterol—chronic obstructive pulmonary disease	0.000398	0.000992	CcSEcCtD
Oxycodone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.000983	CcSEcCtD
Oxycodone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.000983	CcSEcCtD
Oxycodone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.000983	CcSEcCtD
Oxycodone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000395	0.000983	CcSEcCtD
Oxycodone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000394	0.00098	CcSEcCtD
Oxycodone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.000979	CcSEcCtD
Oxycodone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000393	0.000979	CcSEcCtD
Oxycodone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000393	0.000978	CcSEcCtD
Oxycodone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000393	0.000978	CcSEcCtD
Oxycodone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000393	0.000978	CcSEcCtD
Oxycodone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000391	0.000974	CcSEcCtD
Oxycodone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000391	0.000974	CcSEcCtD
Oxycodone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00039	0.000972	CcSEcCtD
Oxycodone—Infection—Montelukast—chronic obstructive pulmonary disease	0.00039	0.000971	CcSEcCtD
Oxycodone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000389	0.00097	CcSEcCtD
Oxycodone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000389	0.00097	CcSEcCtD
Oxycodone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000388	0.000966	CcSEcCtD
Oxycodone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.000962	CcSEcCtD
Oxycodone—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000386	0.00096	CcSEcCtD
Oxycodone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000385	0.000959	CcSEcCtD
Oxycodone—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000384	0.000957	CcSEcCtD
Oxycodone—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000384	0.000956	CcSEcCtD
Oxycodone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000381	0.00095	CcSEcCtD
Oxycodone—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00038	0.000946	CcSEcCtD
Oxycodone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.000943	CcSEcCtD
Oxycodone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.000943	CcSEcCtD
Oxycodone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.000937	CcSEcCtD
Oxycodone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.000933	CcSEcCtD
Oxycodone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000375	0.000933	CcSEcCtD
Oxycodone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000373	0.000928	CcSEcCtD
Oxycodone—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000372	0.000927	CcSEcCtD
Oxycodone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.000924	CcSEcCtD
Oxycodone—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000371	0.000923	CcSEcCtD
Oxycodone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.00092	CcSEcCtD
Oxycodone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.000916	CcSEcCtD
Oxycodone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000366	0.000911	CcSEcCtD
Oxycodone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000366	0.000911	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000365	0.00091	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000365	0.00091	CcSEcCtD
Oxycodone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.000903	CcSEcCtD
Oxycodone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000363	0.000903	CcSEcCtD
Oxycodone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.000899	CcSEcCtD
Oxycodone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00036	0.000898	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000358	0.000891	CcSEcCtD
Oxycodone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000357	0.00089	CcSEcCtD
Oxycodone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000357	0.00089	CcSEcCtD
Oxycodone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000356	0.000888	CcSEcCtD
Oxycodone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.000888	CcSEcCtD
Oxycodone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000355	0.000884	CcSEcCtD
Oxycodone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.000881	CcSEcCtD
Oxycodone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000353	0.000879	CcSEcCtD
Oxycodone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000353	0.000879	CcSEcCtD
Oxycodone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000353	0.000878	CcSEcCtD
Oxycodone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000351	0.000875	CcSEcCtD
Oxycodone—Injury—Prednisone—chronic obstructive pulmonary disease	0.000349	0.00087	CcSEcCtD
Oxycodone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000349	0.000869	CcSEcCtD
Oxycodone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000348	0.000867	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000346	0.000862	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000346	0.000862	CcSEcCtD
Oxycodone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000346	0.000861	CcSEcCtD
Oxycodone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000346	0.000861	CcSEcCtD
Oxycodone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000346	0.000861	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.000859	CcSEcCtD
Oxycodone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.000854	CcSEcCtD
Oxycodone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000343	0.000854	CcSEcCtD
Oxycodone—Pain—Formoterol—chronic obstructive pulmonary disease	0.000343	0.000854	CcSEcCtD
Oxycodone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.000854	CcSEcCtD
Oxycodone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.000853	CcSEcCtD
Oxycodone—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000342	0.000851	CcSEcCtD
Oxycodone—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000342	0.000851	CcSEcCtD
Oxycodone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.000846	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000339	0.000844	CcSEcCtD
Oxycodone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000339	0.000843	CcSEcCtD
Oxycodone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.00084	CcSEcCtD
Oxycodone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.000838	CcSEcCtD
Oxycodone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000336	0.000836	CcSEcCtD
Oxycodone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000335	0.000834	CcSEcCtD
Oxycodone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000333	0.00083	CcSEcCtD
Oxycodone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000332	0.000827	CcSEcCtD
Oxycodone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000332	0.000826	CcSEcCtD
Oxycodone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.000823	CcSEcCtD
Oxycodone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00033	0.000823	CcSEcCtD
Oxycodone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00033	0.000822	CcSEcCtD
Oxycodone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.000819	CcSEcCtD
Oxycodone—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000329	0.000819	CcSEcCtD
Oxycodone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000328	0.000818	CcSEcCtD
Oxycodone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000328	0.000816	CcSEcCtD
Oxycodone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.000816	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.000814	CcSEcCtD
Oxycodone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.000813	CcSEcCtD
Oxycodone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.000806	CcSEcCtD
Oxycodone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.000806	CcSEcCtD
Oxycodone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000321	0.0008	CcSEcCtD
Oxycodone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.000793	CcSEcCtD
Oxycodone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000318	0.000793	CcSEcCtD
Oxycodone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000317	0.000789	CcSEcCtD
Oxycodone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.000789	CcSEcCtD
Oxycodone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.000789	CcSEcCtD
Oxycodone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000317	0.000789	CcSEcCtD
Oxycodone—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000316	0.000787	CcSEcCtD
Oxycodone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000316	0.000787	CcSEcCtD
Oxycodone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000313	0.00078	CcSEcCtD
Oxycodone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000313	0.000779	CcSEcCtD
Oxycodone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000313	0.000779	CcSEcCtD
Oxycodone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000312	0.000777	CcSEcCtD
Oxycodone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.000777	CcSEcCtD
Oxycodone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000311	0.000775	CcSEcCtD
Oxycodone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000311	0.000775	CcSEcCtD
Oxycodone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00031	0.000773	CcSEcCtD
Oxycodone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00031	0.000773	CcSEcCtD
Oxycodone—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00031	0.000772	CcSEcCtD
Oxycodone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.000771	CcSEcCtD
Oxycodone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000307	0.000765	CcSEcCtD
Oxycodone—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000306	0.000763	CcSEcCtD
Oxycodone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000306	0.000761	CcSEcCtD
Oxycodone—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000305	0.00076	CcSEcCtD
Oxycodone—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000304	0.000757	CcSEcCtD
Oxycodone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000301	0.000749	CcSEcCtD
Oxycodone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.000745	CcSEcCtD
Oxycodone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.000745	CcSEcCtD
Oxycodone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000295	0.000736	CcSEcCtD
Oxycodone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.000736	CcSEcCtD
Oxycodone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000295	0.000735	CcSEcCtD
Oxycodone—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000295	0.000733	CcSEcCtD
Oxycodone—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000294	0.000733	CcSEcCtD
Oxycodone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000289	0.00072	CcSEcCtD
Oxycodone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.000716	CcSEcCtD
Oxycodone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000288	0.000716	CcSEcCtD
Oxycodone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000284	0.000706	CcSEcCtD
Oxycodone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.000706	CcSEcCtD
Oxycodone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000282	0.000702	CcSEcCtD
Oxycodone—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000279	0.000696	CcSEcCtD
Oxycodone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.000695	CcSEcCtD
Oxycodone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000278	0.000692	CcSEcCtD
Oxycodone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000274	0.000683	CcSEcCtD
Oxycodone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.000683	CcSEcCtD
Oxycodone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.000676	CcSEcCtD
Oxycodone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000269	0.000669	CcSEcCtD
Oxycodone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.000667	CcSEcCtD
Oxycodone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00066	CcSEcCtD
Oxycodone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00066	CcSEcCtD
Oxycodone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00026	0.000647	CcSEcCtD
Oxycodone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.000645	CcSEcCtD
Oxycodone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000636	CcSEcCtD
Oxycodone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000255	0.000635	CcSEcCtD
Oxycodone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000255	0.000635	CcSEcCtD
Oxycodone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.000629	CcSEcCtD
Oxycodone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000253	0.000629	CcSEcCtD
Oxycodone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.000629	CcSEcCtD
Oxycodone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000253	0.000629	CcSEcCtD
Oxycodone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000251	0.000625	CcSEcCtD
Oxycodone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.000625	CcSEcCtD
Oxycodone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000251	0.000625	CcSEcCtD
Oxycodone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.000623	CcSEcCtD
Oxycodone—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00025	0.000623	CcSEcCtD
Oxycodone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00025	0.000622	CcSEcCtD
Oxycodone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000248	0.000617	CcSEcCtD
Oxycodone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000247	0.000616	CcSEcCtD
Oxycodone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000247	0.000615	CcSEcCtD
Oxycodone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000246	0.000613	CcSEcCtD
Oxycodone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.000605	CcSEcCtD
Oxycodone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.000599	CcSEcCtD
Oxycodone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00024	0.000597	CcSEcCtD
Oxycodone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000239	0.000595	CcSEcCtD
Oxycodone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.000594	CcSEcCtD
Oxycodone—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000239	0.000594	CcSEcCtD
Oxycodone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.000594	CcSEcCtD
Oxycodone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000238	0.000593	CcSEcCtD
Oxycodone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.000593	CcSEcCtD
Oxycodone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.000591	CcSEcCtD
Oxycodone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.000582	CcSEcCtD
Oxycodone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000233	0.000581	CcSEcCtD
Oxycodone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.000574	CcSEcCtD
Oxycodone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000563	CcSEcCtD
Oxycodone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00056	CcSEcCtD
Oxycodone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.000557	CcSEcCtD
Oxycodone—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000556	CcSEcCtD
Oxycodone—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000222	0.000553	CcSEcCtD
Oxycodone—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00055	CcSEcCtD
Oxycodone—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000543	CcSEcCtD
Oxycodone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.000541	CcSEcCtD
Oxycodone—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.000541	CcSEcCtD
Oxycodone—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.000532	CcSEcCtD
Oxycodone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.000528	CcSEcCtD
Oxycodone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00021	0.000523	CcSEcCtD
Oxycodone—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000517	CcSEcCtD
Oxycodone—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000513	CcSEcCtD
Oxycodone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000502	CcSEcCtD
Oxycodone—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000201	0.0005	CcSEcCtD
Oxycodone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.000489	CcSEcCtD
Oxycodone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.000485	CcSEcCtD
Oxycodone—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000484	CcSEcCtD
Oxycodone—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000481	CcSEcCtD
Oxycodone—OPRK1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000187	0.00372	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000186	0.00372	CbGpPWpGaD
Oxycodone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000462	CcSEcCtD
Oxycodone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.00366	CbGpPWpGaD
Oxycodone—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.00365	CbGpPWpGaD
Oxycodone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000447	CcSEcCtD
Oxycodone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.000446	CcSEcCtD
Oxycodone—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000445	CcSEcCtD
Oxycodone—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000442	CcSEcCtD
Oxycodone—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000177	0.00044	CcSEcCtD
Oxycodone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000434	CcSEcCtD
Oxycodone—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000433	CcSEcCtD
Oxycodone—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000432	CcSEcCtD
Oxycodone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00043	CcSEcCtD
Oxycodone—OPRK1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00017	0.00339	CbGpPWpGaD
Oxycodone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000423	CcSEcCtD
Oxycodone—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000417	CcSEcCtD
Oxycodone—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000165	0.00329	CbGpPWpGaD
Oxycodone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00041	CcSEcCtD
Oxycodone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00041	CcSEcCtD
Oxycodone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000164	0.00328	CbGpPWpGaD
Oxycodone—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000408	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000407	CcSEcCtD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000163	0.00326	CbGpPWpGaD
Oxycodone—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000163	0.00325	CbGpPWpGaD
Oxycodone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000405	CcSEcCtD
Oxycodone—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000162	0.00323	CbGpPWpGaD
Oxycodone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.000398	CcSEcCtD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00016	0.00319	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000159	0.00317	CbGpPWpGaD
Oxycodone—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000158	0.00315	CbGpPWpGaD
Oxycodone—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000393	CcSEcCtD
Oxycodone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000393	CcSEcCtD
Oxycodone—OPRM1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000158	0.00315	CbGpPWpGaD
Oxycodone—Infection—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00039	CcSEcCtD
Oxycodone—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000156	0.00311	CbGpPWpGaD
Oxycodone—Shock—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000387	CcSEcCtD
Oxycodone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000385	CcSEcCtD
Oxycodone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000383	CcSEcCtD
Oxycodone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000382	CcSEcCtD
Oxycodone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00038	CcSEcCtD
Oxycodone—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000151	0.00302	CbGpPWpGaD
Oxycodone—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000375	CcSEcCtD
Oxycodone—OPRM1—TCR Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.000149	0.00297	CbGpPWpGaD
Oxycodone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000148	0.00295	CbGpPWpGaD
Oxycodone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000146	0.00291	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000146	0.00291	CbGpPWpGaD
Oxycodone—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000145	0.0029	CbGpPWpGaD
Oxycodone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000358	CcSEcCtD
Oxycodone—OPRM1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000144	0.00287	CbGpPWpGaD
Oxycodone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000358	CcSEcCtD
Oxycodone—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000143	0.00286	CbGpPWpGaD
Oxycodone—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000355	CcSEcCtD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000143	0.00285	CbGpPWpGaD
Oxycodone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000353	CcSEcCtD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00014	0.00279	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000139	0.00278	CbGpPWpGaD
Oxycodone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000346	CcSEcCtD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000138	0.00276	CbGpPWpGaD
Oxycodone—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000138	0.00275	CbGpPWpGaD
Oxycodone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000342	CcSEcCtD
Oxycodone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000341	CcSEcCtD
Oxycodone—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000137	0.00273	CbGpPWpGaD
Oxycodone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000341	CcSEcCtD
Oxycodone—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000339	CcSEcCtD
Oxycodone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000339	CcSEcCtD
Oxycodone—OPRD1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000136	0.00271	CbGpPWpGaD
Oxycodone—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.00271	CbGpPWpGaD
Oxycodone—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.00269	CbGpPWpGaD
Oxycodone—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000336	CcSEcCtD
Oxycodone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.00266	CbGpPWpGaD
Oxycodone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.00265	CbGpPWpGaD
Oxycodone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000324	CcSEcCtD
Oxycodone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000321	CcSEcCtD
Oxycodone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.000321	CcSEcCtD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000128	0.00255	CbGpPWpGaD
Oxycodone—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000312	CcSEcCtD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000125	0.0025	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000125	0.00249	CbGpPWpGaD
Oxycodone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000311	CcSEcCtD
Oxycodone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000311	CcSEcCtD
Oxycodone—OPRD1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000123	0.00246	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000122	0.00243	CbGpPWpGaD
Oxycodone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00012	0.00239	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000119	0.00238	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000118	0.00236	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000118	0.00235	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000117	0.00234	CbGpPWpGaD
Oxycodone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000289	CcSEcCtD
Oxycodone—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000116	0.00231	CbGpPWpGaD
Oxycodone—OPRM1—TCR Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000115	0.0023	CbGpPWpGaD
Oxycodone—OPRD1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000115	0.00229	CbGpPWpGaD
Oxycodone—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000114	0.00228	CbGpPWpGaD
Oxycodone—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000282	CcSEcCtD
Oxycodone—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000113	0.00225	CbGpPWpGaD
Oxycodone—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000278	CcSEcCtD
Oxycodone—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000111	0.00221	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00011	0.00219	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000109	0.00218	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000109	0.00217	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000108	0.00216	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000108	0.00216	CbGpPWpGaD
Oxycodone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000269	CcSEcCtD
Oxycodone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.00214	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000107	0.00213	CbGpPWpGaD
Oxycodone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.00212	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000106	0.00211	CbGpPWpGaD
Oxycodone—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000105	0.00209	CbGpPWpGaD
Oxycodone—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000104	0.00026	CcSEcCtD
Oxycodone—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000103	0.00207	CbGpPWpGaD
Oxycodone—OPRK1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000101	0.00201	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000101	0.00201	CbGpPWpGaD
Oxycodone—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.0001	0.00025	CcSEcCtD
Oxycodone—Rash—Prednisone—chronic obstructive pulmonary disease	9.95e-05	0.000248	CcSEcCtD
Oxycodone—OPRD1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.95e-05	0.00199	CbGpPWpGaD
Oxycodone—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.94e-05	0.00199	CbGpPWpGaD
Oxycodone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.94e-05	0.000247	CcSEcCtD
Oxycodone—Headache—Prednisone—chronic obstructive pulmonary disease	9.88e-05	0.000246	CcSEcCtD
Oxycodone—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.81e-05	0.00196	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.73e-05	0.00194	CbGpPWpGaD
Oxycodone—OPRD1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	9.7e-05	0.00194	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.62e-05	0.00192	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	9.6e-05	0.00192	CbGpPWpGaD
Oxycodone—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.6e-05	0.00192	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	9.53e-05	0.0019	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	9.5e-05	0.0019	CbGpPWpGaD
Oxycodone—Nausea—Prednisone—chronic obstructive pulmonary disease	9.37e-05	0.000233	CcSEcCtD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	9.25e-05	0.00185	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	9.14e-05	0.00183	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	9.01e-05	0.0018	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	8.72e-05	0.00174	CbGpPWpGaD
Oxycodone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.7e-05	0.00174	CbGpPWpGaD
Oxycodone—OPRM1—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	8.7e-05	0.00174	CbGpPWpGaD
Oxycodone—OPRM1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	8.52e-05	0.0017	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	8.5e-05	0.0017	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.43e-05	0.00168	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.33e-05	0.00166	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.12e-05	0.00162	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	8.12e-05	0.00162	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	8.05e-05	0.00161	CbGpPWpGaD
Oxycodone—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8e-05	0.0016	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	8e-05	0.0016	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.71e-05	0.00154	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.66e-05	0.00153	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.57e-05	0.00151	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.46e-05	0.00149	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.37e-05	0.00147	CbGpPWpGaD
Oxycodone—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.36e-05	0.00147	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.33e-05	0.00146	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.29e-05	0.00146	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	7.19e-05	0.00143	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	7.13e-05	0.00142	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.13e-05	0.00142	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.07e-05	0.00141	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	7.04e-05	0.00141	CbGpPWpGaD
Oxycodone—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.97e-05	0.00139	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.87e-05	0.00137	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.76e-05	0.00135	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.63e-05	0.00132	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.39e-05	0.00128	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.36e-05	0.00127	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.28e-05	0.00125	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.24e-05	0.00125	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.14e-05	0.00123	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.02e-05	0.0012	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.88e-05	0.00117	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.87e-05	0.00117	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.71e-05	0.00114	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.69e-05	0.00114	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.58e-05	0.00111	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.47e-05	0.00109	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.4e-05	0.00108	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.38e-05	0.00107	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.37e-05	0.00107	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.31e-05	0.00106	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.3e-05	0.00106	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.23e-05	0.00104	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	5.15e-05	0.00103	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.15e-05	0.00103	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.15e-05	0.00103	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.09e-05	0.00102	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.89e-05	0.000976	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.88e-05	0.000974	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.88e-05	0.000974	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.81e-05	0.00096	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.79e-05	0.000957	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.71e-05	0.00094	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.62e-05	0.000923	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.62e-05	0.000923	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.56e-05	0.00091	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.55e-05	0.000908	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.35e-05	0.000869	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.35e-05	0.000869	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.3e-05	0.000858	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.28e-05	0.000854	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.13e-05	0.000825	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.99e-05	0.000797	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.98e-05	0.000795	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.9e-05	0.000778	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	3.85e-05	0.000769	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.77e-05	0.000752	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.77e-05	0.000752	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.72e-05	0.000742	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.69e-05	0.000736	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.67e-05	0.000732	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.61e-05	0.000722	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	3.51e-05	0.000702	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.5e-05	0.000699	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.41e-05	0.00068	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.32e-05	0.000662	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.29e-05	0.000658	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.24e-05	0.000646	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.23e-05	0.000645	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.18e-05	0.000636	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.01e-05	0.000602	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.99e-05	0.000598	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.96e-05	0.000591	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.91e-05	0.000581	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.89e-05	0.000577	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.88e-05	0.000575	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.82e-05	0.000562	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.78e-05	0.000556	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.73e-05	0.000545	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.7e-05	0.000539	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.68e-05	0.000535	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.66e-05	0.000532	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.64e-05	0.000527	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.62e-05	0.000524	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	2.54e-05	0.000507	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.53e-05	0.000504	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.48e-05	0.000495	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.46e-05	0.000492	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.46e-05	0.000491	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.44e-05	0.000487	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.4e-05	0.000478	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.35e-05	0.00047	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.35e-05	0.000469	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.34e-05	0.000467	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.23e-05	0.000446	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.23e-05	0.000445	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.22e-05	0.000443	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.2e-05	0.00044	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.14e-05	0.000426	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.1e-05	0.00042	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.01e-05	0.000401	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2e-05	0.0004	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.99e-05	0.000396	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.98e-05	0.000395	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.95e-05	0.00039	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.93e-05	0.000386	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.93e-05	0.000384	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.84e-05	0.000368	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.000361	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.79e-05	0.000358	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.78e-05	0.000355	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.76e-05	0.000351	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.7e-05	0.000339	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.69e-05	0.000338	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.66e-05	0.000332	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.63e-05	0.000326	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.61e-05	0.000321	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.6e-05	0.000319	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.56e-05	0.000312	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.56e-05	0.000311	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.53e-05	0.000305	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.49e-05	0.000297	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.48e-05	0.000296	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.45e-05	0.000289	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.41e-05	0.000282	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.39e-05	0.000277	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.37e-05	0.000273	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.33e-05	0.000265	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.32e-05	0.000263	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.31e-05	0.000261	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.3e-05	0.00026	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.29e-05	0.000258	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.28e-05	0.000255	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.27e-05	0.000253	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.25e-05	0.00025	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000241	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.19e-05	0.000238	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.18e-05	0.000236	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.16e-05	0.000232	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.16e-05	0.000231	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.14e-05	0.000228	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.11e-05	0.000221	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.09e-05	0.000218	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.09e-05	0.000217	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.07e-05	0.000214	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1e-05	0.0002	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.83e-06	0.000196	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.64e-06	0.000192	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.58e-06	0.000191	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.08e-06	0.000181	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.95e-06	0.000179	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.77e-06	0.000175	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.34e-06	0.000166	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	8.22e-06	0.000164	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.1e-06	0.000162	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.91e-06	0.000158	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.86e-06	0.000157	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.41e-06	0.000148	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.37e-06	0.000107	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.14e-06	0.000103	CbGpPWpGaD
